Skip to content

A comparison of suprapubic and transurethral catheterization on postoperative urinary retention after vaginal prolapse repair.

A comparison of suprapubic and transurethral catheterization on postoperative urinary retention after vaginal prolapse repair.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24810
Enrollment
116
Registered
2008-11-08
Start date
2005-07-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary retention Cystocele repair Suprapubic catheterization Transurethral catheterization Vaginal prolapse surgery

Interventions

1. Suprapubic catheterization after cystocele correction. 2. Transurethral catheterization after cystocele correction.

Sponsors

Deventer Ziekenhuis, Deventer, the Netherlands
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Women sceduled for surgical correction of cystocele (women undergoing prolapse surgery without the correction of cystocele did not meet the inclusion criteria; patients who were planned for a procedure combining prolapse surgery with any technique for correction of incontinence, e.g. tension-free vaginal tape, were also not eligible).

Exclusion criteria

Exclusion criteria: 1. History of urinary retention. 2. Urinary tract infection at the time of randomizaton. 3. History of urological disease or renal insufficiency. 4. Unability to speak and read the Dutch language.

Design outcomes

Primary

MeasureTime frame
Urinary residual volume, defined as the percentage of patients with a residual volume more than 150 ml after spontaneous voidance the morning of the fourth postoperative day, following clamping (SP) or removing (TU) the catheter the evening before.

Secondary

MeasureTime frame
1. Need for prolonged catheterization; 2. Length of hospital stay; 3. Number of patients with residual volumes exceeding 500 ml; 4. Need for recatheterization; 5. Rate of urinary tract infections; 6. Rate of complications.

Contacts

Public ContactPaul J.Q. Linden, van der

Deventer Ziekenhuis Department of Obstetrics & Gynecology

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)